Therapeutic Contraindications in Exotic Pets.

Area of Science:

• Veterinary Medicine
• Pharmacology
• Exotic Animal Health

Background:

• Extralabel drug use is common in exotic pets.
• Limited pharmacokinetic and pharmacodynamic data exist for these species.
• Dosing is often extrapolated from domestic animals, lacking species-specific safety data.

Purpose of the Study:

• To review drugs with documented contraindications in exotic pet species.
• To provide information on pathophysiology, clinical signs, and treatment for adverse drug events.
• To improve safe medication selection and dosing in exotic animals.

Main Methods:

• Literature review of scientific articles and veterinary drug references.
• Identification of drugs with known adverse effects or contraindications in specific exotic species.
• Compilation of information on drug mechanisms, toxicity, and management strategies.

Main Results:

• Several common medications pose significant risks to certain exotic species.
• Bioavailability and therapeutic levels vary greatly between exotic species.
• Lack of species-specific safety data contributes to potential toxicity.

Conclusions:

• Extralabel drug use in exotic pets requires extreme caution.
• Veterinarians must be aware of species-specific drug contraindications.
• Further research on exotic animal pharmacology is essential for patient safety.